Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1713 to 1762 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5917.23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6322.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06853\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5918.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6323.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6070.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6485.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06844\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6069.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6484.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06842\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9720.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9099.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06831\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mannose-6-phosphate isomerase (ec 5.3.1.8) (phosphomannose isomerase) (pmi) (phosphohexomutase). [source:swissprot;acc:p34949]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative ankyrin-repeat containing protein. [source:refseq;acc:nm\_025185]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin fat 2 precursor (hfat2) (multiple epidermal growth factor-like domains 1). [source:swissprot;acc:q9nyq8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cadherin-related tumor suppressor homolog precursor (fat protein homolog). [source:swissprot;acc:q14517]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mln64 n-terminal domain homolog (stard3 n-terminal like protein). [source:swissprot;acc:o95772]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucose-6-phosphate isomerase (ec 5.3.1.9) (gpi) (phosphoglucose isomerase) (pgi) (phosphohexose isomerase) (phi) (neuroleukin) (nlk) (sperm antigen-36) (sa-36). [source:swissprot;acc:p06744]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6051.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal 3,2-trans-enoyl-coa isomerase (ec 5.3.3.8) (dodecenoyl-coa delta-isomerase) (d3,d2-enoyl-coa isomerase) (dbi-related protein 1) (drs-1) (hepatocellular carcinoma-associated antigen 88). [source:swissprot;acc:o75521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7048.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7527.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0679\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 2 (pl scramblase 2) (ca(2+)-dependent phospholipid scramblase 2). [source:swissprot;acc:q9nry7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6260.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6685.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06783\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba138e2.1.2 (formin-binding protein 17 (fbp17), isoform 2). [source:sptrembl;acc:q96lh6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5475.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5127.66\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06782\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 3 (pl scramblase 3) (ca(2+)-dependent phospholipid scramblase 3). [source:swissprot;acc:q9nry6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6259.8\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6684.31\vspace{3pt}}&\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 4 (pl scramblase 4) (ca(2+)-dependent phospholipid scramblase 4). [source:swissprot;acc:q9nrq2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6684.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin b2. [source:swissprot;acc:q03252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5840.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6236.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 7 precursor (ec 3.4.25.1) (proteasome subunit z) (macropain chain z) (multicatalytic endopeptidase complex chain z). [source:swissprot;acc:q99436]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5781.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6173.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06768\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor 1 a-1) (eef1a-1) (elongation factor tu) (ef-tu). [source:swissprot;acc:p04720]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.83\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6272.26\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06765\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc-finger protein zpr1 (zinc finger protein 259). [source:swissprot;acc:o75312]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-alpha 2 (ef-1-alpha-2) (elongation factor 1 a-2) (eef1a-2) (statin s1). [source:swissprot;acc:q05639]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
twinkle; likely ortholog of mouse t7 gp4-like protein with intramitochondrial nucleoid localization. [source:refseq;acc:nm\_021830]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5925.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6326.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06763\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ischemia/reperfusion inducible protein. [source:refseq;acc:nm\_024640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5885.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6282.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06761\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate synthase (ec 6.3.4.5) (citrulline--aspartate ligase). [source:swissprot;acc:p00966]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5695.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06743\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase plk (ec 2.7.1.-) (plk-1) (serine- threonine protein kinase 13) (stpk13). [source:swissprot;acc:p53350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5878.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6274.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06738\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase dcamkl1 (ec 2.7.1.-) (doublecortin- like and cam kinase-like 1). [source:swissprot;acc:o15075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6297.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6721.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06734\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein, rp/eb family, member 2; t-cell activation protein, eb1 family; apc-binding protein eb1. [source:refseq;acc:nm\_014268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6298.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6722.61\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06729\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine-rich membrane protein ke4. [source:swissprot;acc:q92504]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6298.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6722.65\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein rp/eb family member 1 (apc-binding protein eb1). [source:swissprot;acc:q15691]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein rp/eb family member 3 (protein eb3). [source:swissprot;acc:q9upy8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6298.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6722.62\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
regucalcin gene promotor region related protein; rgpr-p117. [source:refseq;acc:nm\_033127]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5683.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6065.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06728\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cerebral cell adhesion molecule. [source:refseq;acc:nm\_016174]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9596.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10241.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06724\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
doublecortin (lissencephalin-x) (lis-x) (doublin). [source:swissprot;acc:o43602]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6301.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6724.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06723\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein alpha-subunit, mitochondrial precursor (alpha-etf). [source:swissprot;acc:p13804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7919.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8452.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06721\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 34 kda subunit (p34-arc) (actin-related protein 2/3 complex subunit 2). [source:swissprot;acc:o15144]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5384.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5746.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06715\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60 kda tat interactive protein (tip60) (hiv-1 tat interactive protein) (cpla(2) interacting protein). [source:swissprot;acc:q92993]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6011.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6414.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06711\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6339.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 2 (eukaryotic translation initiation factor 2 beta subunit) (eif-2-beta). [source:swissprot;acc:p20042]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5423.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5787.46\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06707\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 2 (ec 3.6.3.4) (copper pump 2) (wilson disease-associated protein). [source:swissprot;acc:p35670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6340.32\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain y-like protein 2. [source:refseq;acc:nm\_152342]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7101.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7577.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3582.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3357.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.067\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific chromodomain y protein 1. [source:swissprot;acc:q9y6f8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7101.15\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7576.84\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06699\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain protein, y chromosome-like isoform a; cdy-like, autosomal; testis-specific chromodomain y-like protein. [source:refseq;acc:nm\_004824]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific chromodomain protein y protein 2. [source:swissprot;acc:q9y6f7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7101.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7576.87\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5693.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6075.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06698\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7794.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8316.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor susceptibility gene 101 protein. [source:swissprot;acc:q99816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6122.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6531.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06672\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/